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THE initial clinical trials of a drug usually only provide information pertaining to
its use in strictly defined circumstances, often with a small number of highly trained
observers. For this reason, when the circumstances permit, this should be followed
by a 'group trial' prior to its general release. The purpose of this is to provide
information, often not obtained from the controlled clinical trials and, in the case
of drugs used during anaesthesia, to ascertain how the new agent will fit into
routine clinical practice. It also tests the acceptability of the new drug to a large
number of practising anaesthetists in a wide variety of clinical situations. This
paper reports a group trial of Althesin involving 2,800 administrations by 70
anaesthetists.
Althesin is a combination of two steroids, alphaxalone and alphadolone acetate,
with Cremophor EL acting as solvent (Child et al, 1971). Initial clinical studies
in several centres suggested that it could prove to be an acceptable intravenous
anaesthetic (Campbell et al, 1971; Clarke et al, 1971; Savege et al, 1971).
ORGANISATION OF THE TRIAL
This group trial was modelled on a previous study of propanidid reported by
Clarke and Dundee in 1966. One full-time organiser was responsible for its co-
ordination. An initial letter introducing the drug and outlining the purpose of the
trial was sent to every anaesthetist in Northern Ireland. Those who expressed
willingness to participate were visited personally and given forty 5 ml ampoules
of Althesin, a brief factual summary of its pharmacology and appropriate record
sheets for their observations. They were requested to use the drug for 40 cases in
their routine clinical practice with an induction dose of 50 ,ul/kg. Premedication
was left entirely to the personal choice of the anaesthetist concerned.
The anaesthetist was asked to keep an appropriate record of each administration
and particularly to record the occurrence of side effects during induction of anaes-
thesia such as excitatory phenomena-tremor, muscle movement, hypertonus;
respiratory upset-cough, hiccough, laryngospasm and respiratory depression, with
or without apnoea; fluctuation in pulse rate and blood pressure etc. Each induction
of anaesthesia was to be graded as follows according to the scheme described by
Dundee, Moore and Nicholl (1962):
Grade (1) - Smooth uncomplicated induction;
Grade (2a} - 'Induction with minor side effects not interfering with anaesthesia or
surgery;
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endanger the patient's life;
Grade (3) - Major side effects which could endanger the patient's life or make
surgery impossible.
Each anaesthetist was asked to complete a five page questionnaire consisting of
two main sections, the first of which he was asked to answer after his first twenty
cases and the second after a further twenty cases. Pharmacological and physical
properties of Althesin were compared with other induction agents with which he was
familiar. In addition anaesthetists were asked to express an opinion as to the likely
future of Althesin in clinical anaesthesia. It was stressed that this reply was to be
based on their own personal impressions and not on the published work of others.
Finally, they were asked about any particular difficulties encountered during the
use of Althesin and also to record any other individual comments about the drug.
Completed questionnaires often with detailed reports, were obtained from 70
anaesthetists of varying seniority and experience. Half of the participants were
consultants and the remainder junior anaesthetist staff. Twenty-five clinicians had
previous experience with a group trial, either with methohexitone or propanidid.
Althesin was administered to 2,800 patients undergoing a wide variety of sur-
gical procedures including cardiothoracic, dental and neurosurgery. On 396
occasions Althesin was employed for out-patient anaesthesia and also used to
induce anaesthesia in 269 paediatric patients, i.e. children aged 10 years and
younger. In approximately 12 per cent of patients Althesin was employed as a sole
agent either as a single dose or used intermittently with incremental doses. In the
remainder of patients the new steroid agent was used purely for induction of
anaesthesia and a wide variety of inhalation agents and muscle relaxants were
subsequently added for maintenance of anaesthesia (Table 1).
TABLE I
Inhalation agents and muscle relaxants employed following induction
of anaesthesia uwith Althesin
No. of Muscle No. of
Inhalation agents patients relaxants patients
Nitrous oxide/oxygen 706 Suxamethonium 823
,, /halothane 1493 Pancuronium 205
,,9 /methoxyflurane 104 Tubocurarine 85
,,% /trichloroethylene 61 Gallamine 75
,,9 /intravenous analgesia 80 Alcuronium 3
RESULTS
Induction of Anaesthesia
Table II lists the individual induction complications. Involuntary muscle move-
ment occurred in approximately 18 per cent of patients and was the commonest
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sidered muscle movement as being troublesome or potentially dangerous. The
relatively low incidence of respiratory tract irritation, i.e. cough, laryngospasm
and hiccough is noteworthy.
TABLE II
Incidence of side effects during induction of anaesthesia with Althesin
No. of
Complication patients Percentage
Involuntary muscle movement 501 17.9
Cardiovascular depression* 172 6.1
Respiratory depression 121 4.3
Inadequate depth of anaesthesia 111 4.0
Hypertonus 90 3.2
Cough 79 2.8
Hiccough 69 2.5
Flushing of skin 63 2.3
Slow onset 26 0.9
Laryngospasm 23 0.8
Others - e.g. excessive salivation 23 0.8
*Cardiovascular depression is taken as a fall in systolic blood pressure in excess of 20 mm
mercury.
Approximately two-thirds of the 2,800 inductions were completely trouble-free.
In a further 769 cases there was some minor upset which did not interfere with
the conduct of anaesthesia or surgery. The remaining 5 per cent of inductions
were considered to be unsatisfactory. Of these, some incident occurred in 134
patients which interfered with the course of anaesthesia and/or delayed the onset
of surgery. However, in only 12 instances was this of sufficient severity (grade 3)
as to make surgery impossible or place the patient's life at risk. The factors
responsible for these serious upsets included failure of induction of sleep, severe
hypotension or laryngospasm.
Comparison with other agents (Table Ill)
Excitatory phenomena: Eighty-two per cent of participants thought that Althesin
caused less excitatory phenomena than methohexitone, and only one anaesthetist
considered it to be worse. However, 41 anaesthetists thought that the new drug
was slightly worse, and two thought it to be much worse than thiopentone in this
respect. Only 10 per cent thought that excitatory effects were less with Althesin
than with thiopentone. Opinion was evenly divided as to whether the new steroid
was either no different or an improvement on propanidid.
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Opinion of 70 anaesthetists on the relative merits of Althesin as compared
with thiopentone, methohexitone and propanidid
Althesin considered to be:
Criterion for compared with: Criterion
, compari Better Not different Slightly worse Much worse comparison Althesin
Number of Anaesthetists
Smoothness Thiopentone 12 41 17 0
of induction Methohexitone 51 17 2 0
Propanidid 56 13 1 0
Excitatory Thiopentone 7 20 41 2
phenomena Methohexitone 57 12 1 0
Propanidid 27 31 11 1
Cardiovascular Thiopentone 39 27 4 0
depression Methohexitone 14 47 9 0
Propanidid 42 23 5 0
Respiratory Thiopentone 55 14 1 0
depression Methohexitone 36 32 2 0
Propanidid 27 31 11 1
Duration of Thiopentone 61 9 0 0
recovery Methohexitone 24 37 9 0
Propanidid 2 16 33 19
Character of Thiopentone 51 17 2 0
recovery Methohexitone 32 34 4 0
Propanidid 13 42 12 3
Ease of Thiopentone 42 21 6 1
administration Methohexitone 34 29 6 1
Propanidid 56 14 0 0
Three-quarters of the anaesthetists were of the opinion that Althesin provided
a smoother induction of anaesthesia than methohexitone and propanidid. Only 12
anaesthetists thought Althesin better than thiopentone and in fact 24 per cent
considered the steroid to be slightly less smooth than thiopentone.
Cardiovascular depression: There was no clear cut opinion as to the relative
cardiovascular effects of Althesin compared to other agents. Fifty-six and 60 per
cent of anaesthetists considered it to be less depressant than thiopentone and
propanidid respectively, while two-thirds thought it was not significantly different
than methohexitone in this respect.
Respiratory depression: In the opinion of the anaesthetists in this group trial,
Althesin produced much less depression of respiration than equivalent doses of
thiopentone. However, approximately half of them considered Althesin to be not
different from methohexitone. A few anaesthetists thought that propanidid caused
less respiratory depression than Althesin.
154Recovery: A large majority of participants considered recovery with Althesin
to be more rapid than with thiopentone; nobody thought it to be slower than the
barbiturate. Approximately half found no difference between the speed of recovery
with Althesin and methohexitone. However, 74 per cent of anaesthetists con-
sidered Althesin to be slower in the recovery phase than propanidid.
A favourable impression was created with respect to the clarity of recovery
following Althesin. When compared with thiopentone, 51 thought the steroid to be
an improvement; with methohexitone opinion was almost equally divided as to
whether Althesin was better or not different. Eighty-one per cent of anaesthetists
did not consider Althesin to be an improvement on propandid with regard to the
character of recovery.
Ease of administration: When considering the small volume of the anaesthetic
agent required, also the fact that the drug comes ready in solution and does not
require mixing, 60 per cent of anaesthetists thought that the steroid anaesthetic
was more convenient to use in the clinical situation than thiopentone, and this view
was held in spite of its increased viscosity compared to the water soluble bar-
biturates. Fewer anaesthetists considered Althesin better than methohexitone,
largely as a result of the smaller volume of 2 per cent methohexitone necessary
when compared to 2.5 per cent thiopentone and the fact that most methohexitone
is dispensed from multi-dose bottles. Many anaesthetists thought Althesin was an
improvement on propanidid on the basis of decreased viscosity and a smaller
volume of solution required. Nobody considered it to be more difficult to administer
than propanidid.
The overall opinion of the participants with regard to the viscosity was that
52 did not consider it a practical problem. With regard to the volume of solution
46 anaesthetists approved of working with 5 ml syringes.
Others: In the study anaesthetists were also asked to note any suspected drug
interactions; however, 57 found no evidence of any interaction. The remaining
13 anaesthetists found some information suggesting a drug interaction most fre-
quently involving suxamethonium (Table IV). Other suspected interactions were
tachycardia with methoxyflurane, increased excitatory phenomena with hyoscine
premedication and resistance in alcoholic patients.
Overall opinion
Twenty-one anaesthetists thought that Althesin was a 'safe' anaesthetic, and
many used it as their drug of choice in the 'poor risk' patient; 10 felt that it was
suitable for use as sole agent either as a single dose for short procedures or used
intermittently for longer operations. It was surprising to find that 16 observers
thought that the onset of sleep was slower by a few seconds than with other con-
ventional induction agents, although this feature was not considered a hindrance
in practice. Ten anaesthetists who found 50 ul/kg to be inadequate felt that if the
dose was increased to 60 ,lA/kg or 75 pd/kg better results would have been obtained.
The concensus of opinion shown in Table V was that Althesin was likely to
have a place in clinical anaesthesia. It was felt that the steroid was less likely to
replace thiopentone than methohexitone. Of the 15 anaesthetists who thought
155Althesin would just become an additional drug, four were doubtful that the drug
had any clinical usefulness. The majority of anaesthetists thought that Althesin
was most suitable for minor surgical and out-patient procedures. However, 30
considered the steroid to be a suitable drug for routine induction of anaesthesia for
major as well as minor surgery.
TABLE IV
Frequency of reports of suspected interactions by 13 anaesthetists
Numberof
Suspected drug interaction Reports
Shorter action of suxamethonium 5
Increased duration of suxamethonium 2
Increased suxamethonium fasiculations 2
Hypertension with suxamethonium 2
Increased excitatory phenomena with hyoscine premedication 3
Tachycardia with methoxyflurane 1
Tachycardia with gallamine 1
Prolonged action of pancuronium 1
Resistance in alcoholics 1
TABLE V
The overall opinion of 70 anaesthetists regarding the clinical
usefulness of Althesin
Number who regarded Althesin as:
A replacement for Thiopentone - 10
Methohexitone - 23
Propanidid - 22
An alternative drug of little proven advantage - 15
70
Number who thought its place was for:
Minor surgery and outpatient anaesthesia - 40
Routine induction of anaesthesia - 30
70
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The optimal induction dose of Althesin is 50-60 jl/kg (Clarke et al, 1971).
During this trial the percentage incidence of acceptable inductions at this dose
resembles closely that found by other workers (Clarke et al, 1971). The commonest
reported complication during induction of anaesthesia was involuntary muscle
movement which occurred in 18 per cent of patients, this again being similar to
previous reports (Swerdlow, Chakravorty and Zahangir, 1971). Three anaesthetists
reported an increased incidence of excitatory phenomena with hyoscine pre-
medication and this also confirms previous reports (Clarke et al, 1972>.
The most frequent reports of suspected drug interactions involved suxa-
methonium. Some thought that it intensified and others that it antagonised the
action of this relaxant. This is an erroneous view as there is both experimental and
clinical evidence to show that Althesin behaves in an identical fashion to the
barbiturates with respect to its duration of action of suxamethonium (Healy,
Birmingham and Chatterjee, 1972; Carson, Clarke and Dundee, 1973; Foley et al,
1972). The absence of interaction with other anaesthetic drugs has thus far been a
feature of Althesin (Campbell, Miller and Bradford, 1972).
Only nine out of 70 anaesthetists considered the recovery following Althesin
to be longer than after methohexitone which is surprising since most experimental
evidence would support this view (Foley et al, 1972; Hannington-Kiff, 1972). Work
in progress in this department shows that recovery times with 50-60 jL/kg of the
steroid are much closer to those of equipotent doses of thiopentone, than prev-
iously suspected, but when larger doses of each are used, then recovery is quicker
after Althesin.
SUMMARY
Seventy anaesthetists took part in a 'group trial' of Althesin as an intravenous
anaesthetic agent. The induction characteristics and the side effects of this drug
were studied and compared with thiopentone, methohexitone and propanidid.
The opinions expressed on a questionnaire suggest that Althesin will be a widely
used drug for induction of anaesthesia in both in-patients and out-patients.
Twenty-one per cent of anaesthetists thought that the new steroid agent, although
safe and pleasant to use, was of little proven clinical advantage over other more
conventional intravenous anaesthetics.
157ACKNOWLEDGEMENTS
The author was in receipt of a grant from Glaxo Laboratories Ltd. and wishes to thank
Dr. J. A. Sutton for adequate supplies of Althesin.
The author is indebted to each and every anaesthetist who gave of their time to participate
in this 'group trial'.
It is a pleasure to thank Professor J. W. Dundee and Dr. R. S. J. Clarke for help in the
preparation of this paper.
REFERENCES
CAMPBELL, D., FORRESTER, A. C., MILLER, D. C., HUTTON, I., KENNEDY, J. A., LAWRIE,
T. D. V., LORIMER, A. R. and MCCALL, D. (1971). Brit. J. Anaesth., 43, 14.
CAMPBELL, D., MILLER, D. C. and BRADFORD, M. W. (1972). Postgrad. med. J. Suppl. 2., 48,
123.
CARSON, I. W., CLARKE, R. S. J. and DUNDEE, J. W. (1973). Brit. J. Pharmacol., 47, 679.
CHILD, K. J., CURRIE, J. P., DAVIs, B., DODDS, M. G., PEARCE, D. R. and TWISSELL, D. J.
(1971). Brit. J. Anaesth., 43, 2.
CLARKE, R. S. J. and DUNDEE, J. W. (1966). Ulster Medical Journal, 35, 44.
CLARKE, R. S. J., DUNDEE. J. W., CARSON, I. W., ARORA, M. V. and MCCAUGHEY, W. (1972).
Brit. J. Anaesth., 44, 845.
CLARKE, R. S. J., MONTGOMERY, S. J., DUNDEE, J. W. and BOVILL, J. G. (1971). Brit. J.
Anaesth., 43, 947.
DUNDEE, J. W., MOORE, J. and NICHOLL, R. M. (1962). Brit. J. Anaesth., 34, 523.
FOLEY, E. I., WALTON, B., SAVEGE, T. M., STRUNIN, L. and SIMPSON, B. R. (1972). Postgrad.
med. J., Suppl. 2, 48, 112.
HANNINGTON KIFF, J. G. (1972). Postgrad. med. J., Suppl. 2, 48, 116.
HEALY, T. E. J., BIRMINGHAM, A. J. and CHATrERJEE, S. C. (1972). Postgrad. med. J., Suppl. 2,
48, 90.
SAVEGE, T. M., FOLEY, E. I., COULTAS, R. J., WALTON, B., STRUNIN, L., SIMPSON, B.R. and
SCorr, D. F. (1971). Anaesthesia, 26, 402.
SWERDLOW, M., CHAGRAVORTY, S. K. and ZAHANGIR, M. A. H. (1971). Brit. J. Anaesth., 43,
1075.
158